EoE: Not just an elimination diet, for an elimination diet that works

Published Date: 08 Mar 2023

Eliminating milk alone not only reduces the symptoms of patients with eosinophilic esophagitis, but also improves quality of life.

Read Full News

Latest News

China Steps Up Ebola Monitoring With Revised Prevention Plan

China on Tuesday issued a revised prevention and control plan for the Ebola epidemic, requiring ⁠close contacts of Ebola cases to undergo tracking and quarantined medical...

Kennedy Orders American Exposed to Hantavirus to Stay Quarantined Against Her Will, WSJ Reports

U.S. Health Secretary Robert F. Kennedy Jr. has ordered an American passenger exposed to hantavirus on a cruise ship to remain in quarantine despite medical advice and...

Rare Genetic Disorders in Children: What Raises Suspicion?

Experts outline the clinical features that may signal rare genetic disorders, helping pediatricians identify affected children, and accelerate specialist referrals.

Managing C difficile in IBD: New Guidance From the AGA

The co-occurrence of IBD and Clostridioides difficile poses unique diagnostic and management challenges. A new American Gastroenterological Association statement updates earlier 2017 guidance.

Mapping the Clitoris Changes Women's Health

A profound lack of anatomical research into the clitoris has left the medical community blind to the root causes of postpartum nerve damage and chronic pelvic pain.

Congo Ebola Response Strained a Month After WHO Declares International Emergency

Health workers battling an Ebola outbreak in eastern Democratic Republic of Congo lack the personnel to identify suspected cases, the ambulances to transport them and even...

Todays Updates

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Euthanasia should not be allowed for people seeking to be killed by medical professionals exclusively for mental illness reasons, according to a report published on...

New Immune Therapy Boosts Disease Control in Prostate Cancer

An adenoviral-based immunotherapy improved disease-free survival in men with localized intermediate- or high-risk disease, but experts had reservations.

Todays Updates

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Euthanasia should not be allowed for people seeking to be killed by medical professionals exclusively for mental illness reasons, according to a report published on...

New Immune Therapy Boosts Disease Control in Prostate Cancer

An adenoviral-based immunotherapy improved disease-free survival in men with localized intermediate- or high-risk disease, but experts had reservations.

Latest News

China on Tuesday issued a revised prevention and control plan for the Ebola epidemic, requiring ⁠close contacts of Ebola cases to undergo tracking and quarantined medical...

U.S. Health Secretary Robert F. Kennedy Jr. has ordered an American passenger exposed to hantavirus on a cruise ship to remain in quarantine despite medical advice and...

Experts outline the clinical features that may signal rare genetic disorders, helping pediatricians identify affected children, and accelerate specialist referrals.

The co-occurrence of IBD and Clostridioides difficile poses unique diagnostic and management challenges. A new American Gastroenterological Association statement updates earlier 2017 guidance.

A profound lack of anatomical research into the clitoris has left the medical community blind to the root causes of postpartum nerve damage and chronic pelvic pain.

Health workers battling an Ebola outbreak in eastern Democratic Republic of Congo lack the personnel to identify suspected cases, the ambulances to transport them and even...

News All Time

Reducing Readmissions: What Works?

With more hospitals expected to face readmission penalties, hospitals continue efforts to decrease readmissions. Two programs that focus on keeping in touch with patients postdischarge are helping.

Sound Wave Therapy Improves Kids’ Congestion

High adherence and absence of adverse events support the feasibility of nondrug treatment.

Promising Results for Sonelokimab in Early-Phase axSpA Trial

Results of the phase 2, open-label, single-arm S-OLARIS study provide ‘proof of concept’ that the novel IL-17A/F-inhibiting nanobody has an effect on patients with axial spondyloarthritis.

Now We Can Remove Microplastics From the Body: Does It Help?

Researchers used a basic procedure to lower microplastic levels in the body, but no one knows if this benefits the patient or how long until new plastics leach back in.

Peanut Allergy Labels Removed in One Third of Infants

Formal food challenges before oral immunotherapy allowed early delabelling of peanut allergy in more than one third of Australian infants despite prior reactions and evidence of sensitization.

Wearable Diabetes Devices: Triggers Behind Most Dermatitis

A patch-testing study highlights the compounds that account for most of the contact dermatitis from insulin infusion and glucose monitoring devices.

Adrenaline Falls Short in Anaphylaxis Model

Standard intramuscular adrenaline doses failed to restore blood pressure in most participants exposed to a controlled histamine challenge mimicking severe anaphylaxis.

Nipocalimab Outshines Placebo in Phase 2b Lupus Study

A higher percentage of participants treated with nipocalimab 15 mg/kg met the primary endpoint of an SLE Responder Index-4 composite response at week 24 than placebo.

Unusually Warm Canadian Temperatures a Harbinger of Ticks

Experts warn that new tick species in Canada can confound diagnosis.

Health Workers Struggle to Contain Ebola in Congo Camps as Distrust Grows

After the Kpangba displacement camp became the first in this part of war-torn Congo to record deaths from Ebola two weeks ago, health ⁠workers rushed to trace those who had...

Immigrant Docs at Center of Storm as Court Battles Intensify

Rapid changes to federal immigration policy including travel bans mean uncertain futures for many immigrant physicians and medical students hoping to enter or remain in the US.

Jazz Pharmaceuticals Lung Cancer Drug Fails Main Trial Goal

Jazz Pharmaceuticals said on Friday its lung cancer drug Zepzelca failed to meet the main goal ⁠of improving overall survival in a late-stage study, potentially risking its...

New Score May Improve Pediatric Anaphylaxis Care

A new risk score stratifies children’s risk for biphasic anaphylaxis and could reduce unnecessary emergency department observation for most patients.

Four JAK Inhibitors Have Positive Late-Stage Trial Results

Data from phase 3 studies with filgotinib, gecacitinib, and ivarmacitinib and a phase 4 study of tofacitinib in early disease are reported.

Nasal Steroids May Not Affect Treatment Response in EoE

The concurrent use of intranasal and/or inhaled steroids or coexisting allergic rhinitis does not affect treatment response in patients with eosinophilic esophagitis receiving topical corticosteroids.

SAT Offers Hope for Prosthetic Vascular Graft Infection Care

Suppressive antimicrobial therapy is a viable option for patients with prosthetic vascular graft infection who are at a high surgical risk.

Recommended News For You

The Kansas Cancer Center awarded two Indian American doctors professorships.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

Have the Harms of Lung Cancer Screening Been Exaggerated?

Recommended Articles For You

Understanding Iron Saturation Levels in Your Blood  

Oncological Surgery Today: Personalized, Interdisciplinary Approaches to Cancer Care 

The Growing Crisis of Aplastic Anemia: A Call for Action 

AI-Powered Rehabilitation: A Game Changer for Hemophilia Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Urinary tract cancer prediction models with high sensitivity and specificity

2.

Two medications might work better for breast cancers that are resistant to one.

3.

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness

4.

When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.

5.

No Solace From Drug Scarcities; Novel Guidelines Regarding Lymphedema; A "Good" Patient Is Forgotten.

1.

The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy 

2.

Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System

3.

ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer

4.

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care

5.

Hematopoietic Aging and Long-Term Disease Risk: Mechanisms, Clinical Impact, and Emerging Therapeutic Strategies

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

2.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot